On July 27th, 2023, Clarivate Plc introduced German hospital prescribing insights within Clarivate Patient Data Intelligence (CPDI). This anonymised data product offers insights into treatments dispensed in German hospitals. It provides a view into market trends, patient traits, and specialty prescribing patterns across various diseases.
—
About Clarivate
Clarivate Plc, a publicly traded analytics company, is renowned for offering diverse subscription-based services. In the academic and scientific community, Clarivate is recognised for calculating the impact factor, using data from its Web of Science product family. This includes services/applications such as Publons, EndNote, EndNote Click, and ScholarOne.
Leading in real-world data solutions
With this product, CPDI emerges as the first supplier. This strengthens Clarivate’s role as a top provider of real-world data solutions in Europe. The data, sourced from hospital EHR software, covers both in-patient and out-patient care in Germany.
Broadening CPDI capabilities
The new insights significantly boost CPDI capabilities. The enhanced system allows life science professionals to examine drug volumes prescribed by various physician specialties. This aids pharmaceutical companies in identifying specialties showing more interest in their products versus their competitors.
Providing crucial intelligence for healthcare
Zoe Barker, Clarivate’s Vice President of Product, highlighted the challenges in analysing real-world data products. Such difficulties can impede the success of drug launches. However, with these new insights, Clarivate continues to deliver superior intelligence to life science and healthcare organisations.
Insight into patient behaviour
Patient Data Intelligence is a fast, user-friendly platform that offers an anonymised view of dispensing and prescribing patterns, and patient behaviour. It supports life science professionals in making informed decisions in key European markets, including Italy, France, Spain, and Germany.
Investment in healthcare’s future
Clarivate’s ongoing investment in Patient Data Intelligence addresses the need to engage patients, physicians, and payers innovatively. The company is committed to investing in advanced technologies, including artificial intelligence and machine learning. This supports customers’ efforts to tackle healthcare’s most significant challenges throughout the drug, device and medical technology lifecycle.
If you are looking to take big strides in the world of data, you need the right people. We can help with that: contact a PL Talents recruitment expert today.